Acta Scientific Paediatrics (ISSN: 2581-883X)

Mini Review Volume 3 Issue 3

Neonatal Immunization: Challenges and Future Scenario

Pradeep Kumar Gupta*

MD Pediatrics, IAP Fellow Neonatology, Norvic International Hospital, Nepal

*Corresponding Author: Pradeep Kumar Gupta, MD Pediatrics, IAP Fellow Neonatology, Norvic International Hospital, Nepal.

Received: January 29, 2020; Published: February 10, 2020


  Infections are one of the greatest toll in early life requiring strong approaches to protect the very young. Here, we review neonatal immunization - the knowledge, its present state, and future scenario.

Keywords: Neonatal Immunization; Infections; HIV



  1. W.H.O. The World Health Report. World Health Organization (2005).
  2. Clemens J., et al. “Ten years of the global alliance for vaccines and immunization: challenges and progress”. Nature Immunology 11 (2010): 1069-1072.
  3. Liu L., et al. “Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals”. Lancet 388 (2016): 3027-3035.
  4. Stoll BJ., et al. “Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network”. Pediatrics 110 (2002): 285-291.
  5. Langkamp DL and Davis JP. “Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children”. Journal of Pediatrics 128 (1996): 654-659. 
  6. Gaudelus J., et al. “Is the new vaccination schedule recommended in France adapted to premature babies?”. Archives of Pediatrics 21 (2014): 1062-1070.
  7. CA American Academy of Pediatrics. “Immunization of preterm and low birth weight infants”. Pediatrics 112 (2003): 193-198. 
  8. Kollmann TR., et al. “Innate immune function by toll-like receptors: distinct responses in newborns and the elderly”. Immunity 37 (2012): 771-783.
  9. Guidelines for Vaccinating Pregnant Women. Atlanta, CDC (2014). 
  10. Offit P and Hackett C. “Multiple Vaccines and the Immune System”. In: Plotkin, SA.; Orenstein, WA., editors. Vaccines. Fourth Edn.. Saunders; Philadelphia (2004): 1583-1589.
  11. Goriely S and Goldman M. “From tolerance to autoimmunity: is there a risk in early life vaccination?” Journal of Comparative Pathology 137 (2007): S57-61.
  12. Gruber C., et al. “Do early childhood immunizations influence the development of atopy and do they cause allergic reactions?” Pediatric Allergy and Immunology 12 (2011): 296-311.
  13. Morein B., et al. “Immune responsiveness in the neonatal period”. Journal of Comparative Pathology 137 (2007): S27-31.
  14. Douglas RM., et al. “Antibody response to pneumococcal vaccination in children younger than five years of age”. Journal of Infection Disease 148 (1983): 131-137.
  15. Siba P., et al. “Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea”. Clinical Trials, U.S. National Institutes of Health (2008).
  16. Shann F. “Substantial benefits from finding the most effective BCG strain”. Lancet Respiratory Medicine 4 (2016): e35.
  17. Saadatian-Elahi M., et al. “Heterologous vaccine effects”. Vaccine 34 (2016): 3923-30.
  18. Committee on Infectious Diseases, Committee on Fetus and Newborn. “Elimination of perinatal hepatitis B: providing the first vaccine dose within 24 hours of birth”. Pediatrics 140 (2017): e20171870.
  19. van Montfoort N., et al. “Hepatitis B virus surface antigen activates myeloiddendritic cells via a soluble CD14-dependent mechanism”. Journal of Virology 90 (2016): 6187-6199.
  20. World Health Organization. “Polio vaccines: WHO position paper, March 2016-recommendations”. Vaccine 35 (2017): 1197-1199.
  21. Aponte JJ., et al. “Safety of the RTS,S/ AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial”. Lancet 370 (2007): 1543-1551.
  22. Garcon N., et al. “GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives”. Expert Review of Vaccines 6 (2007): 723-739.
  23. Ota MO., et al. “Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination”. Journal of Immunology 168 (2002): 919-925.


Citation: Pradeep Kumar Gupta. “Neonatal Immunization: Challenges and Future Scenario”. Acta Scientific Paediatrics 3.3 (2020): 24-27.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US